Sym004: Phase I/II started

Symphogen began an open-label, dose-escalation, international Phase I/II trial to evaluate 0.4 to 12 mg/kg IV Sym004 given once weekly in patients. The Phase I portion will evaluate Sym004 in 42 patie...